Literature DB >> 32522821

Recent advances in percutaneous coronary intervention.

Stephen P Hoole1, Paul Bambrough2.   

Abstract

Percutaneous coronary intervention (PCI) continues to advance at pace with an ever-broadening indication. In this article we will review the recent technological advances in PCI that have enabled more complex coronary disease to be treated. The choice of revascularisation strategy must take into account the evidence-just because we can treat by PCI does not necessarily mean we should. When PCI is indicated, a safe, precision PCI approach guided by physiology, imaging and optimal lesion preparation should be the goal to obtain complete revascularisation and a durable long-term result. When these standards are adhered to, the outcomes can be excellent, in even complex coronary disease. We provide contemporary trial evidence to justify PCI and treatment algorithms that ensure optimal revascularisation decision making to achieve the best patient outcomes. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  percutaneous coronary intervention

Mesh:

Year:  2020        PMID: 32522821     DOI: 10.1136/heartjnl-2019-315707

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  9 in total

1.  Proteomics Revealed That Mitochondrial Function Contributed to the Protective Effect of Herba Siegesbeckiae Against Cardiac Ischemia/Reperfusion Injury.

Authors:  Xiaohong Wei; Yuzhuo Wu; Haie Pan; Qian Zhang; Ke He; Guiyang Xia; Huan Xia; Sheng Lin; Hong-Cai Shang
Journal:  Front Cardiovasc Med       Date:  2022-07-06

Review 2.  Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation.

Authors:  Eva Montalvá; Manuel Rodríguez-Perálvarez; Annabel Blasi; Santiago Bonanad; Olga Gavín; Loreto Hierro; Laura Lladó; Elba Llop; Juan Carlos Pozo-Laderas; Jordi Colmenero
Journal:  Transplantation       Date:  2022-01-04       Impact factor: 5.385

3.  The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.

Authors:  Pengfei Wang; Haixia Qiao; RuiJuan Wang; Ruitian Hou; Jingtao Guo
Journal:  BMC Cardiovasc Disord       Date:  2020-12-04       Impact factor: 2.298

Review 4.  Physiologic Assessment after Coronary Stent Implantation.

Authors:  Doyeon Hwang; Seokhun Yang; Jinlong Zhang; Bon Kwon Koo
Journal:  Korean Circ J       Date:  2021-03       Impact factor: 3.243

5.  Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.

Authors:  Lina Lv; Xianying Yuan; Lihong Jiang
Journal:  Medicine (Baltimore)       Date:  2022-02-25       Impact factor: 1.817

6.  Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients.

Authors:  Qiuxuan Li; Xiaoteng Ma; Qiaoyu Shao; Zhiqiang Yang; Yufei Wang; Fei Gao; Yujie Zhou; Lixia Yang; Zhijian Wang
Journal:  Front Cardiovasc Med       Date:  2022-05-03

7.  Predicting the Risk of Unplanned Readmission at 30 Days After PCI: Development and Validation of a New Predictive Nomogram.

Authors:  Wenjun Xu; Hui Tu; Xiaoyun Xiong; Ying Peng; Ting Cheng
Journal:  Clin Interv Aging       Date:  2022-07-05       Impact factor: 3.829

8.  A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients.

Authors:  Qiang Feng; Ying Zhao; Haiyan Wang; Jiayu Zhao; Xun Wang; Jianping Shi
Journal:  Front Cardiovasc Med       Date:  2022-08-11

9.  Drug-Coated Balloon vs. Stent for de novo Non-small Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Authors:  Kaiwen Sun; Zhenzhu Liu; Hongyan Wang
Journal:  Front Cardiovasc Med       Date:  2021-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.